Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry.

Chi Chiu MokHo SoCheuk Wan YimChi Hung ToWeng Nga LaoStella Pui Yan WongHoi Yan NgJolly Man Yee LeePatrick Man Leung LeeShirley King Yee YingMoon Ho LeungCarmen Tze Kwan Ho

Published in: Rheumatology (Oxford, England) (2023)

In a real-life setting, there is no increase in MACEs or cancers in users of the JAKis compared with the TNFis. However, the incidence of non-serious infections, including herpes zoster, was increased in users of the JAKis.

Keyphrases

rheumatoid arthritis
disease activity
electronic health record
risk factors
big data
data analysis
young adults
systemic lupus erythematosus